A lack of association between severity of nicotine withdrawal and individual differences in compensatory nicotine self-administration in rats
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
RationaleCompensatory smoking may represent an adverse consequence of smoking reduction or the use of reduced-nicotine tobacco products. Factors contributing to individual variability in compensation are poorly understood.ObjectiveThe objective of this study was to examine whether severity of nicotine withdrawal as measured by elevated intracranial self-stimulation (ICSS) thresholds is related to individual differences in compensatory nicotine self-administration (NSA) following unit dose reduction.MethodsRats were trained for ICSS and NSA (0.06 mg/kg per infusion). After stabilization, effects of reducing the nicotine unit dose to 0.03 mg/kg per infusion were examined. Following reacquisition of NSA (0.06 mg/kg per infusion), effects of antagonist-precipitated withdrawal and saline extinction (spontaneous withdrawal) were examined.ResultsReducing the NSA unit dose produced partial compensation as indicated by the increased infusion rates, but a 35% mean decrease in daily nicotine intake. The magnitude of compensation varied considerably among rats. Dose reduction did not elicit withdrawal in rats as a group, although there were substantial increases in ICSS thresholds in some animals. Intracranial self-stimulation thresholds were consistently elevated during precipitated and spontaneous withdrawal, confirming that rats were nicotine-dependent. Individual differences in compensation were not correlated with changes in ICSS thresholds during dose reduction, precipitated withdrawal, or spontaneous withdrawal. In a secondary analysis, greater precipitated withdrawal severity predicted greater initial nicotine seeking during extinction.ConclusionsSeverity of nicotine withdrawal was not related to the degree of compensation in this protocol. These data do not support a role for nicotine withdrawal in individual differences in compensation during reduced nicotine exposure, but do suggest that withdrawal may contribute to nicotine seeking during early abstinence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guidelines on nicotine dose selection for in vivo research
Matta, S. G., Balfour, D. J., Benowitz, N. L., Boyd, R. T., Buccafusco, J. J., Caggiula, A. R., Craig, C. R., Collins, A. C., Damaj, M. I., Donny, E. C., et al. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0441-0 · Cited by 824
Dramatic decreases in brain reward function during nicotine withdrawal
Epping-Jordan, M. P., Watkins, S. S., Koob, G. F., & Markou, A. (1998) · Nature · doi:10.1038/30001 · Cited by 674 · cited 1×
“The primary measure of withdrawal was elevation in intracranial self-stimulation (ICSS) threshold, indicative of the deficit in brain reinforcement processes (anhedonia) that accompanies withdrawal (Epping-Jordan et al. 1998; Markou and Koob 1991).”
BackgroundPharmacology of Nicotine: Addiction and Therapeutics
Benowitz, N. L. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.003121 · Cited by 589 · cited 2×
“R. Pentel:M. G. LeSage Department of Medicine, Hennepin County Medical Center, Minneapolis, MN 55404, USA Psychopharmacology DOI 10.1007/s00213-011-2273-9 tobacco (e.g., Benowitz 1996; 2008; U.S.”
InfluentialNeural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal
S. Watkins, G. F. K. (2000) · Nicotine & Tobacco Research · doi:10.1080/14622200050011277 · Cited by 424
Neurobiological evidence for hedonic allostasis associated with escalating cocaine use
Ahmed, S. H., Kenny, P. J., Koob, G. F., & Markou, A. (2002) · Nature Neuroscience · doi:10.1038/nn872 · Cited by 389 · cited 2×
“This control condition is commonly used in studies examining the effects of drug selfadministration on ICSS (e.g., Ahmed et al. 2002 ; K enny et al. 2006, 2009; Kenny and Markou 2006).”
Clearing the smoke: the science base for tobacco harm reduction—executive summary
Stratton, K., Shetty, P., Wallace, R., & Bondurant, S. (2001) · Tobacco Control · doi:10.1136/tc.10.2.189 · Cited by 313 · cited 1×
“Tobacco harm reduction is being evaluated as an alternative or transitional stage toward cessation for smokers who are unable or unwilling to quit (Britton and Edwards 2008; Hatsukami et al. 2007; Shiffman et al. 2002; Stratton et al. 2001).”
BackgroundKenny, P. J., & Markou, A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300905 · Cited by 261
Watkins, S. S., Stinus, L., Koob, G. F., & Markou, A. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35389-3 · Cited by 214 · cited 2×
“Avoidance of the aversive aspects of nicotine withdrawal has been hypothesized to contribute to smoking behavior (e.g., Watkins et al. 2000a, b), and nicotine withdrawal severity is a known predictor of cessation success (Hughes 2007; Piasecki et al. 1998, 2003).”
Piasecki, T. M., Fiore, M. C., & Baker, T. B. (1998) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.107.2.238 · Cited by 189
Hughes, J. (2007) · Nicotine & Tobacco Research · doi:10.1080/14622200701188927 · Cited by 173 · cited 2×
“2000a, b), and nicotine withdrawal severity is a known predictor of cessation success (Hughes 2007; Piasecki et al. 1998, 2003).”
Research works printed but not linked: 52
- Benowitz NL (2008) Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clin Pharmacol Ther 83:531–541 · DOI · Paper page
- Benowitz NL, Dains KM, Hall SM, Stewart S, Wilson M, Dempsey D, Jacob P 3rd (2009) Progressive commercial cigarette yield reduction: biochemical exposure and behavioral assessment. Cancer Epidemiol Biomark Prev 18:876–883 · DOI
- Benowitz NL, Hall SM, Stewart S, Wilson M, Dempsey D, Jacob P 3rd (2007) Nicotine and carcinogen exposure with smoking of progressively reduced nicotine content cigarette. Cancer Epidemiol Biomark Prev 16:2479–2485 · DOI
- Benowitz NL, Henningfield JE (1994) Establishing a nicotine threshold for addiction. The implications for tobacco regulation. N Engl J Med 331:123–125 · DOI · Paper page
- Benowitz NL, Jacob P 3rd, Bernert JT, Wilson M, Wang L, Allen F, Dempsey D (2005) Carcinogen exposure during short-term switching from regular to “light” cigarettes. Cancer Epidemiol Biomark Prev 14:1376–1383 · DOI
- Benowitz NL, Jacob P 3rd, Herrera B (2006) Nicotine intake and dose response when smoking reduced-nicotine content cigarettes. Clin Pharmacol Ther 80:703–714 · DOI · Paper page
- Benowitz NL, Jacob P 3rd, Kozlowski LT, Yu L (1986) Influence of smoking fewer cigarettes on exposure to tar, nicotine, and carbon monoxide. N Engl J Med 315:1310–1313 · DOI · Paper page
- Britton J, Edwards R (2008) Tobacco smoking, harm reduction, and nicotine product regulation. Lancet 371:441–445 · DOI
- Brower VG, Fu Y, Matta SG, Sharp BM (2002) Rat strain differences in nicotine self-administration using an unlimited access paradigm. Brain Res 930:12–20 · DOI
- Corrigall WA (1999) Nicotine self-administration in animals as a dependence model. Nicotine Tob Res 1:11–20 · DOI · Paper page
- Corrigall WA, Coen KM (1989) Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology 99:473–478 · DOI · Paper page
- DeNoble VJ, Mele PC (2006) Intravenous nicotine self-administration in rats: effects of mecamylamine, hexamethonium and naloxone. Psychopharmacology 184:266–272 · DOI
- Donny EC, Caggiula AR, Knopf S, Brown C (1995) Nicotine self-administration in rats. Psychopharmacology 122:390–394 · DOI · Paper page
- Donny EC, Caggiula AR, Mielke MM, Booth S, Gharib MA, Hoffman A, Maldovan V, Shupenko C, McCallum SE (1999) Nicotine self-administration in rats on a progressive ratio schedule of reinforcement. Psychopharmacology 147:135–142 · DOI · Paper page
- Epstein DH, Preston KL, Stewart J, Shaham Y (2006) Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure. Psychopharmacology 189:1–16 · DOI · Paper page
- Harris AC, Burroughs D, Pentel PR, LeSage MG (2008) Compensatory nicotine self-administration in rats during reduced access to nicotine: an animal model of smoking reduction. Exp Clin Psychopharmacol 16:86–97 · DOI
- Harris AC, Mattson C, LeSage MG, Keyler DE, Pentel PR (2010) Comparison of the behavioral effects of cigarette smoke and pure nicotine in rats. Pharmacol Biochem Behav 96:217–227 · DOI
- Harris AC, Pentel PR, LeSage MG (2007) Prevalence, magnitude, and correlates of an extinction burst in drug-seeking behavior in rats trained to self-administer nicotine during unlimited access (23 h/day) sessions. Psychopharmacology 194:395–402 · DOI
- Harris AC, Pentel PR, LeSage MG (2009) Correlates of individual differences in compensatory nicotine self-administration in rats following a decrease in nicotine unit dose. Psychopharmacology 205:599–611 · DOI
- Hatsukami DK, Henningfield JE, Kotlyar M (2004) Harm reduction approaches to reducing tobacco-related mortality. Ann Rev Public health 25:1–19 · DOI · Paper page
- Hatsukami DK, Joseph AM, Lesage M, Jensen J, Murphy SE, Pentel PR, Kotlyar M, Borgida E, Le C, Hecht SS (2007) Developing the science base for reducing tobacco harm. Nicotine Tob Res 9(Suppl 4):S537–553 · DOI · Paper page
- Hatsukami DK, Kotlyar M, Hertsgaard LA, Zhang Y, Carmella SG, Jensen JA, Allen SS, Shields PG, Murphy SE, Stepanov I, Hecht SS (2010a) Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation. Addiction 105:343–355 · DOI · Paper page
- Hatsukami DK, Le CT, Zhang Y, Joseph AM, Mooney ME, Carmella SG, Hecht SS (2006) Toxicant exposure in cigarette reducers versus light smokers. Cancer Epidemiol Biomark Prev 15:2355–2358 · DOI
- Hatsukami DK, Perkins KA, Lesage MG, Ashley DL, Henningfield JE, Benowitz NL, Backinger CL, Zeller M (2010b) Nicotine reduction revisited: science and future directions. Tob Control 19:e1–10 · DOI
- Hecht SS, Murphy SE, Carmella SG, Zimmerman CL, Losey L, Kramarczuk I, Roe MR, Puumala SS, Li YS, Le C, Jensen J, Hatsukami DK (2004) Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen. J Natl Cancer Inst 96:107–115 · DOI · Paper page
- Henningfield JE, Benowitz NL, Slade J, Houston TP, Davis RM, Deitchman SD (1998) Reducing the addictiveness of cigarettes. Council on Scientific Affairs, American Medical Association. Tob Control 7:281–293 · DOI
- Joseph AM, Hecht SS, Murphy SE, Lando H, Carmella SG, Gross M, Bliss R, Le CT, Hatsukami DK (2008) Smoking reduction fails to improve clinical and biological markers of cardiac disease: a randomized controlled trial. Nicotine Tob Res 10:471–481 · DOI
- Kenny PJ, Chartoff E, Roberto M, Carlezon WA Jr, Markou A (2009) NMDA receptors regulate nicotine-enhanced brain reward function and intravenous nicotine self-administration: role of the ventral tegmental area and central nucleus of the amygdala. Neuropsychopharmacology 34:266–281 · DOI
- Kenny PJ, Chen SA, Kitamura O, Markou A, Koob GF (2006) Conditioned withdrawal drives heroin consumption and decreases reward sensitivity. J Neurosci 26:5894–5900 · DOI · Paper page
- Kornetsky C, Esposito RU (1979) Euphorigenic drugs: effects on the reward pathways of the brain. Fed Proc 38:2473–2476
- LeSage MG, Keyler DE, Collins G, Pentel PR (2003) Effects of continuous nicotine infusion on nicotine self-administration in rats: relationship between continuously infused and self-administered nicotine doses and serum concentrations. Psychopharmacology 170:278–286 · DOI
- LeSage MG, Keyler DE, Shoeman D, Raphael D, Collins G, Pentel PR (2002) Continuous nicotine infusion reduces nicotine self-administration in rats with 23-h/day access to nicotine. Pharmacol Biochem Behav 72:279–289 · DOI
- Lynch WJ, Carroll ME (1999) Regulation of intravenously self-administered nicotine in rats. Exp Clin Psychopharmacol 7:198–207 · DOI
- Markou A, Koob GF (1991) Postcocaine anhedonia. An animal model of cocaine withdrawal. Neuropsychopharmacology 4:17–26
- Markou A, Koob GF (1992) Construct validity of a self-stimulation threshold paradigm: effects of reward and performance manipulations. Physiol Behav 51:111–119 · DOI · Paper page
- Markou A, Paterson NE (2001) The nicotinic antagonist methyllycaconitine has differential effects on nicotine self-administration and nicotine withdrawal in the rat. Nicotine Tob Res 3:361–373 · DOI · Paper page
- Markou A, Weiss F, Gold LH, Caine SB, Schulteis G, Koob GF (1993) Animal models of drug craving. Psychopharmacology 112:163–182 · DOI · Paper page
- O’Dell LE, Chen SA, Smith RT, Specio SE, Balster RL, Paterson NE, Markou A, Zorrilla EP, Koob GF (2007) Extended access to nicotine self-administration leads to dependence: circadian measures, withdrawal measures, and extinction behavior in rats. J Pharmacol Exp Ther 320:180–193 · DOI
- Paterson NE, Balfour DJ, Markou A (2008) Chronic bupropion differentially alters the reinforcing, reward-enhancing and conditioned motivational properties of nicotine in rats. Nicotine Tob Res 10:995–1008 · DOI · Paper page
- Paterson NE, Froestl W, Markou A (2004) The GABAB receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat. Psychopharmacology 172:179–186 · DOI
- Paterson NE, Markou A (2004) Prolonged nicotine dependence associated with extended access to nicotine self-administration in rats. Psychopharmacology 173:64–72 · DOI
- Roiko SA, Harris AC, LeSage MG, Keyler DE, Pentel PR (2009) Passive immunization with a nicotine-specific monoclonal antibody decreases brain nicotine levels but does not precipitate withdrawal in nicotine-dependent rats. Pharmacol Biochem Behav 93:105–111 · DOI
- Rose J, Behm F (2004) Effects of low nicotine content cigarettes on smoke intake. Nicotine Tob Res 6:309–319 · doi:10.1080/14622200410001676378
- Rose JE, Corrigall WA (1997) Nicotine self-administration in animals and humans: similarities and differences. Psychopharmacology 130:28–40 · DOI · Paper page
- Scherer G (1999) Smoking behaviour and compensation: a review of the literature. Psychopharmacology 145:1–20 · DOI · Paper page
- Shiffman S, Gitchell JG, Warner KE, Slade J, Henningfield JE, Pinney JM (2002) Tobacco harm reduction: conceptual structure and nomenclature for analysis and research. Nicotine Tob Res 4(Suppl 2):S113–129 · DOI · Paper page
- Shoaib M, Schindler CW, Goldberg SR (1997) Nicotine self-administration in rats: strain and nicotine pre-exposure effects on acquisition. Psychopharmacology 129:35–43 · DOI · Paper page
- Valentine JD, Hokanson JS, Matta SG, Sharp BM (1997) Self-administration in rats allowed unlimited access to nicotine. Psychopharmacology 133:300–304 · DOI
- Watkins SS, Epping-Jordan MP, Koob GF, Markou A (1999) Blockade of nicotine self administration with nicotinic antagonists in rats. Pharmacol Biochem Behav 62:743–751 · DOI · Paper page
- West RJ, Russell MA, Jarvis MJ, Feyerabend C (1984) Does switching to an ultra-low nicotine cigarette induce nicotine withdrawal effects? Psychopharmacology 84:120–123 · DOI
- Zacny JP, Stitzer ML (1988) Cigarette brand-switching: effects on smoke exposure and smoking behavior. J Pharmacol Exp Ther 246:619–627 · DOI
- Zeller M, Hatsukami D (2009) The Strategic Dialogue on Tobacco Harm Reduction: a vision and blueprint for action in the US. Tob Control 18:324–332 · DOI · Paper page
Cited by
Addiction as a stress surfeit disorder
Koob, G. F., Buck, C. L., Cohen, A., Edwards, S., Park, P. E., Schlosburg, J. E., Schmeichel, B., Vendruscolo, L. F., Wade, C. L., Whitfield, T. W., et al. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.024 · Cited by 483
“Similar results of parallel increases in brain reward thresholds with escalation of nicotine intake have also been observed with extended access to nicotine (Harris et al., 2011).”
ResultThe dark side of emotion: the addiction perspective
Koob, G. F. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.11.044 · Cited by 433
“Similar results have been observed with extended access to methamphetamine (Jang et al., 2013) and heroin (Kenny et al., 2006) and nicotine (Harris et al., 2011).”
ResultAddiction is a Reward Deficit and Stress Surfeit Disorder
Koob, G. F. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00072 · Cited by 397
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337
Metadata
- Authors
- Harris, A. C., Pentel, P. R., Burroughs, D., Staley, M. D., & LeSage, M. G.
- Venue
- Psychopharmacology
- Published
- 2011-04-15
- Volume
- 217
- Issue
- 2
- Pages
- 153-166
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W1984927228
- Cited by
- 44
- References
- 17
- FWCI
- 2.89
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A lack of association between severity of nicotine withdrawal and individual differences in compensatory nicotine self-administration in rats. https://app.cochat.ai/papers/10.1007/s00213-011-2273-9
- The paper
- Harris, A. C., Pentel, P. R., Burroughs, D., Staley, M. D., & LeSage, M. G. (2011). A lack of association between severity of nicotine withdrawal and individual differences in compensatory nicotine self-administration in rats. Psychopharmacology. https://doi.org/10.1007/s00213-011-2273-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.